About us

Dr Paritt is a Research Fellow in the Department of Anatomy and Medical Imaging and the Centre for Brain Research. He is the principle investigator of the clinical study funded by the Lottery Health Research, New Zealand. He has established the research team focusing on non-invasive neuromodulation for adjunctive therapy of neurological conditions with a new approach of the tele clinical trial. He has more than 15-year experience in clinical research using his background in medicine, neurosurgery, and PhD in Deep Brain Stimulation (Imperial College London). He will bring his expertise in biomedical engineering for the development of new interventions to stroke, traumatic brain injury and spinal cord injury research in New Zealand. He holds a NZ Good Clinical Practice (GCP) certificate (2020 and 2022).

As the project leader, he has overall responsibility for the study, including adherence to established ethical standards. His role includes designing the TENS protocol, preparing documents and reports (clinical trial registration, ethical approval, data monitoring safety, research questionnaire, clinical survey). He will conduct the clinical trial (recruitment, interview, follow up, monitor and investigating adverse events) with participants recruited from the community. All procedures have been leveraged into the online platform known as the tele-trial model using video conference, courier services, webpage, mobile app, and secure data storage via the virtual computing machine. He will collect, analyse and interpret the data and will prepare reports and manuscripts for publication in the World’s leading journals and international conferences.

Dr Lawrence is a consultant neuro-urologist at the Auckland Spinal Rehabilitation Unit (ASRU) and Auckland Hospital with sub-specialty training in male and female voiding dysfunction, urinary incontinence, neuromodulation (Interstim® and Tibial Nerve Stimulation). She has been actively involved in clinical research in the field of neurogenic bladder following spinal cord injury and has presented both nationally in New Zealand and internationally.
Dr Lawrence was involved in designing and reviewing the protocol, will be involved in analysis of results and advising on any technical and clinical issues associated with this trial.

Dr Pylypchuk is an epidemiologist and biostatistician at the Department of Epidemiology and Biostatistics, School of Population Health, the University of Auckland. She has broad knowledge and experience in public health and epidemiology and her expertise includes epidemiological study designs, health data management and statistical analysis. Her work on developing clinical prediction models was published in the Lancet, endorsed by the New Zealand Ministry of Health, and is currently being integrated into electronic patient management systems nationally.
Dr Pylypchuk is involved in the trial design and statistical analysis of the data collected in this trial.